Improvements in Survival and Disparities for Advanced-Stage Laryngeal Cancer

被引:23
|
作者
LeBlanc, Blake Joseph [1 ]
Shi, Runhua [2 ]
Mehta, Vikas [1 ]
Mills, Glenn [3 ]
Ampil, Federico [4 ]
Nathan, Cherie-Ann O. [1 ]
机构
[1] Louisiana State Univ Hlth Shreveport, Dept Otolaryngol Head & Neck Surg, Shreveport, LA USA
[2] Louisiana State Univ Hlth Shreveport, Dept Med, Shreveport, LA USA
[3] Louisiana State Univ Hlth Shreveport, Dept Oncol, Shreveport, LA USA
[4] Louisiana State Univ Hlth Shreveport, Dept Radiat Oncol, Shreveport, LA USA
关键词
SQUAMOUS-CELL CARCINOMA; ORGAN PRESERVATION; CARTILAGE INVASION; TRENDS; CHEMOTHERAPY; STRATEGIES; SURGERY; CARE;
D O I
10.1001/jamaoto.2014.2998
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Laryngeal cancer survival rates have declined over the past 2 decades. Primary surgical therapy may increase survival rates in advanced-stage tumors. OBJECTIVE To compare survival outcomes for initial surgical treatment of advanced-stage primary tumors in the Louisiana health system with outcomes in the National Cancer Database (NCDB). DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis was conducted at an academic tertiary referral hospital. Patients diagnosed as having laryngeal carcinoma between 1998 and 2007 were identified via a tumor registry. Louisiana State University Health-Shreveport (LSU Health) data and national data from 2000 to 2010 were obtained from the NCDB of the American College of Surgeons. INTERVENTIONS Treatment of laryngeal cancer. MAIN OUTCOMES AND MEASURES Age, sex, race/ethnicity, socioeconomic status, laryngeal subsite, stage, primary treatment modality, and observed survival were analyzed and compared. RESULTS A total of 165 patients treated at LSU Health met the inclusion criteria. One hundred seventeen (70.91%) presented with advanced-stage (III/IV) disease, compared with 46.67% nationwide (P < .01). For stage IV disease our 5-year survival rate was 55.54%(95% CI, 43.35%-66.11%) compared with 31.60% (95% CI, 30.40%-32.90%) nationally (P < .05). Our proportion of uninsured patients was 23.73% vs 5.05% of patients nationally (P < .001), and our patients traveled further distances for care with 60.47% traveling 50 miles or more, compared with 15.87% nationally (P < .001). Sixty-four of the patients with advanced-stage disease (54.70%) underwent primary surgical therapy to include total laryngectomy. Data from the NCDB indicate that the rate of laryngectomy declined from 40% to 60% in the 1980s to 32% in 2007. CONCLUSIONS AND RELEVANCE Louisiana State University Health-Shreveport treated more uninsured patients with advanced-stage laryngeal cancer compared with national data but demonstrated higher survival rates for those with advanced-stage disease. The results also demonstrate that we have continued a high rate of primary surgical therapy for advanced-stage disease, despite the national trend toward organ preservation. We believe that upfront laryngectomy may explain our higher survival rates for advanced-stage laryngeal cancer.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [21] Racial/Ethnic, Socioeconomic, and Geographic Disparities of Cervical Cancer Advanced-Stage Diagnosis in Texas
    Zhan, F. Benjamin
    Lin, Yan
    WOMENS HEALTH ISSUES, 2014, 24 (05) : 519 - 527
  • [22] Concurrent chemoradiation as a treatment option for advanced-stage laryngeal cancers
    Smith, RB
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (09) : 820 - 820
  • [23] Managing advanced-stage cervical cancer
    Allen, D
    Narayan, K
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2005, 19 (04) : 591 - 609
  • [24] Advanced-stage duodenal cancer in pregnancy
    Root, Emily
    Feng, Xiang Yu
    Dong, Brian
    Miller, Edward
    BMJ CASE REPORTS, 2025, 18 (01)
  • [25] Racial and ethnic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy: A National Cancer Database analysis
    Washington, Caretia J.
    Karanth, Shama D.
    Braithwaite, Dejana
    Akinyemiju, Tomi F.
    CANCER RESEARCH, 2023, 83 (07)
  • [26] ADVANCED LARYNGEAL-CANCER - RELEVANCE OF PATHOLOGICAL STAGE TO SURVIVAL AND THERAPY
    DECKER, JW
    PRICE, JC
    GOLDSTEIN, JC
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1986, 112 (11) : 1163 - 1167
  • [27] Chemotherapy dose reduction is associated with poor survival in advanced-stage ovarian cancer
    Chura, J. C.
    Axtell, A.
    Pavelka, J.
    Boyd, A.
    Downs, L. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S12 - S13
  • [28] Functional outcomes following nonsurgical treatment for advanced-stage laryngeal carcinoma
    Meleca, RJ
    Dworkin, JP
    Kewson, DT
    Stachler, RJ
    Hill, SL
    LARYNGOSCOPE, 2003, 113 (04): : 720 - 728
  • [29] Advanced-stage pancreatic cancer: therapy options
    Werner, Jens
    Combs, Stephanie E.
    Springfeld, Christoph
    Hartwig, Werner
    Hackert, Thilo
    Buechler, Markus W.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (06) : 323 - 333
  • [30] Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer
    Lam, David C. L.
    Tam, Terence C. C.
    Lau, Kenneth M. K.
    Wong, Wai-Mui
    Hui, Christopher K. M.
    Lam, Jamie C. M.
    Wang, Julie K. L.
    Lui, Macy M. S.
    Ho, James C. M.
    Ip, Mary S. M.
    CLINICAL LUNG CANCER, 2015, 16 (06) : 507 - 513